|
Steroid-sparing options offered for skin diseases: an expert's view.(Dermatologic Therapy)
Publication: Skin & Allergy News Publication Date: 01-APR-04 Author: Mahoney, Diana
|
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2004 International Medical News Group
STOWE, VT. -- Infliximab infusions can induce a prompt response in some patients with refractory pyoderma gangrenosum, according to Dr. Peter W. Heald.
The steroid-sparing treatment option for the ulcerative cutaneous condition is one of several "new twists in medical dermatology" that the Yale University physician discussed in a presentation at a dermatology conference sponsored by the University of Vermont.
Using examples from his own practice, Dr. Heald presented "a stamp collection" of treatment advances, drug updates, and information for managing skin diseases that are becoming more prevalent.
Pyoderma gangrenosum can be difficult to treat and often doesn't...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Skin & Allergy News |
Biologics offer dramatic, but brief, response to hidradenitis suppurat...
April 01, 2004
|
Nevirapine can lead to hepatotoxicity in women: medwatch alert.(Dermat...
April 01, 2004
|
AAD presidential priorities.(Policy & Practice)(American Academy of De...
April 01, 2004
|
SkinPAC goals.(Policy & Practice)(Brief Article)
April 01, 2004
|
Bioterrorism preparedness.(Policy & Practice)(Brief Article)
April 01, 2004
|
|
| Find companies classified under Medicinals and botanicals |
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
